Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-03-11 | New | $35,000 | $35,000 | Equity and Debt | 06b | SEC link |
| 2024-09-23 | Amended | $150,000 | $100,000 | Equity and Debt | 06c | SEC link |
| 2024-06-12 | New | $50,000 | $50,000 | Debt Only | 06c | SEC link |
| 2023-11-08 | New | $100,000 | $100,000 | Equity and Debt | 06b | SEC link |
| 2022-04-15 | New | $250,000 | $250,000 | Equity Only | 06c | SEC link |
| 2019-04-29 | Amended | $1,945,773 | $1,145,773 | Equity Only | 06b | SEC link |
| 2018-05-25 | New | $800,000 | $800,000 | Equity Only | 06b | SEC link |
| 2017-08-04 | New | $200,000 | $200,000 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| Steve Buhaly | Executive |
| Bernard A. Fox Iii, Mba | Executive |
| Bernard A. Fox, Iii | Executive |
| Bernard A. Fox, Mba | Executive |
| Bernard A. Fox, Ph.D | Director, Executive |
| Bernard Fox, Ph.D. | Director, Executive |
| Hong Ming Hu, Ph.D | Director, Executive |
| Hong Ming Hu, Ph.D. | Director, Executive |
| Nancy Lime | Executive |
| Sung Poblete, R.N., Ph.D. | Director |
| Jon Wigginton, M.D. | Director |